Jump to:

What do you want from mims.co.uk?

What do you want from mims.co.uk?

Links to SPCs, more patient factsheets, information on drug stock shortages - or something else?

Click on the idea bubble in the bottom right hand corner of the page or go to UserVoice to tell us what new content or functionality you'd like to see on MIMS online.

Vote on existing ideas or suggest one of your own for others to vote on, and help shape development of the site.

More information

MIMS News

First Look | Jaydess: new low-dose intrauterine contraceptive

Bayer has launched Jaydess, a new low-dose intrauterine delivery system that can...

 

Adempas: first soluble guanylate cyclase stimulator for pulmonary hypertension

Bayer has launched a first-in-class treatment Adempas (riociguat) to improve exercise capacity...

 

In Depth | Xolair approved for chronic spontaneous urticaria

Xolair (omalizumab) is now licensed as add-on therapy for the treatment of...

 

In Depth | Spedra launch provides new option for erectile dysfunction

Spedra (avanafil), a new PDE5 inhibitor, has been launched by Menarini for...

 

Protelos: EMA recommends further restrictions for use

The use of Protelos (strontium ranelate) for the treatment of severe osteoporosis...

 

First Look | Mirvaso: first-in-class topical treatment for erythema of rosacea

Mirvaso is a topical gel formulation of the alpha2 agonist, brimonidine, and...

 

News in brief - April 2014

Other new launches, licence changes and updates relevant to general practice.

 

Deleted products 2014

The following products are no longer available and have been removed from...

 

New Products 2014

The following products have become available for the UK market in 2014....

 

NICE approves rituximab for treatment of rare vascular condition

NICE has ruled that rituximab (MabThera) can be considered for the treatment...

 

MHRA highlights reduced contraceptive effect with St John's Wort

The MHRA has highlighted the reduction in efficacy of hormonal contraceptives, including...

 

In Depth | Tecfidera (dimethyl fumarate): new oral MS treatment

Tecfidera (dimethyl fumarate) is now available for the treatment of relapsing-remitting multiple...

 

Latest MIMS Publications

MIMS Dermatology


  • Number 4, 2013
  • Clinical Review: Acne
  • Management of scarring

MIMS

Click here to find out more
  • March–May 2014
  • 27 new products
  • Over 750 updates
  • List of new and deleted products
 

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

Travel Vaccination & Malaria Advice

Travel Vaccination & Malaria Advice

Supplied by the National
Travel Health Network
and Centre (NaTHNaC)

Palliative Care Resources

Palliative Care Resources

Opioid dose conversions
and much more

Back to top